Top news of the week: 28.07.2020.
Pharmacology, Medicine, Antibody, Clinical research, Drugs, Immune system
Healthcare
RT @BioStocks: The Week Ahead In #Biotech
$RARE $VXRT $TCRR $GNCA $ALEC $BTAI $AVXL $BLRX
https://t.co/kbMyKeebii
OpenThe Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks. Although there were promising updates from...
Biopharma Update on the Novel Coronavirus: July 22 https://t.co/Dlz3hcRp72 https://t.co/mYHLfdEZz2
OpenBiopharma Update on the Novel Coronavirus: July 22
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 22, 2020.
RT @Roche: First half of the year with 1% growth at constant exchange rates, significant impact of COVID-19 pandemic. See the full results here: https://t.co/WEUFdSiyoL
$RHHBY $ROG https://t.co/1jP0NN6395
OpenFirst half of the year with 1% growth at constant exchange rates, significant impact of COVID-19 pandemic
Group sales increase 1%1 at constant exchange rates and decline 4% in Swiss francs as a result of continued appreciation of the Swiss franc against most currencies COVID-19 …
RT @JohnCendpts: Gilead’s Kite snares a landmark FDA OK on a CAR-T therapy — which comes with bragging rights to the first true franchise op
$GILD
https://t.co/OBDntBZ5wh
OpenGilead’s Kite snares a landmark FDA OK on a $373,000 CAR-T therapy — which comes with bragging rights to the first true franchise op
While many of the top players in the immuno-oncology field have shifted their focus to new and better CAR-Ts in the pipeline, one of the pioneers in the field is now proudly laying claim to ...
Black people still few and far between in San Diego's biotech industry #BioTech via https://t.co/2sI0UxJbpn https://t.co/J2YkmVZyLW
OpenBlack people still few and far between in San Diego’s biotech industry
An industry known for tackling tough problems still hasn't cracked one: diversity
This Biotech Business Won't Let Cost Get in the Way of a Covid Cure #BioTech #ux via https://t.co/2sI0UxJbpn https://t.co/2it7NVH9JI
OpenThis Biotech Business Won't Let Cost Get in the Way of a Covid Cure
Synthetic gene manufacturer ATUM turned down venture capital. That's why it's free to do whatever it takes to fight Covid-19.
RT @endpts: Amplitude raises $50M to fuel ‘emerging’ Canadian biotech field https://t.co/xxHaT0Ihk9
OpenAmplitude raises $50M to fuel ‘emerging’ Canadian biotech field
Nine months and an IPO since they spun out the Business Development Bank of Canada’s healthcare arm into its own VC, the investors behind Amplitude have raised another $50 million to pour ...
When Raising Drug Prices Helps Patients. By Chris Morrison @CT_Morrison and @PeterKolchinsky https://t.co/JoIEXHq1Lq
OpenWhen Raising Drug Prices Helps Patients
Sometimes there are good, patient-friendly reasons to raise drug prices. Proposed legislation that aims to eliminate price hikes on prescription drugs will have unintended consequences. San ...